Opendata, web and dolomites
H2020 projects about "drugs"
The page lists 796 projects related to the topic "drugs".
| # | |||
|---|---|---|---|
| 1 | BIOCYCLE | BIOlogical therapy CYCLEs towards tailored, needs-driven, safer and cost-effective management of Crohn’s disease | 2015 |
| 2 | DiaChemo | Point-of-care microfluidic device for quantification of chemotherapeutic drugs in small body fluid samples by highly selective nanoparticle extraction and liquid crystal detection | 2015 |
| 3 | INMARE | Industrial Applications of Marine Enzymes: Innovative screening and expression platforms to discover and use the functional protein diversity from the sea | 2015 |
| 4 | GLORIA | Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis | 2015 |
| 5 | REGAIN | REgeneration of inner ear hair cells with GAmma-secretase INhibitors to regain hearing in patients with sensorineural hearing loss | 2015 |
| 6 | nextBioPharmDSP | Next-generation biopharmaceutical downstream process | 2015 |
| 7 | CIRCODE | Cell-type specific mechanisms regulating rhythms in leukocyte homing | 2015 |
| 8 | PentaBrain | Structural studies of mammalian Cys-loop receptors | 2015 |
| 9 | PredicTOOL | Nanomethods to understand what makes an endogenous protein immunogenic | 2015 |
| 10 | SILENCE | Mechanisms of Gene Silencing by the Glucocorticoid Receptor | 2015 |
| 11 | DE-ORPHAN | DEtermination of Orphan Receptor PHysiological Agonists and sigNals | 2015 |
| 12 | CatHet | New Catalytic Asymmetric Strategies for N-Heterocycle Synthesis | 2015 |
| 13 | complexNMR | Structural Dynamics of Protein Complexes by Solid-State NMR | 2015 |
| 14 | SQUALAC | Preclinical development of squalenic acid and gemcitabine squalene nanomedicine | 2015 |
| 15 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 16 | CannaPreg | Development of pregnenolone derivatives as allosteric inhibitors of CB1 cannabinoid receptors for the treatment of schizophrenia and psychotic syndromes | 2015 |
| 17 | IMPARTS | Integral Membrane Proteins – an Approach to Rank Target Stability | 2015 |
| 18 | ONCORNET | ONCOgenic Receptor Network of Excellence and Training | 2015 |
| 19 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 20 | NABBA | Design and development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseases | 2015 |
| 21 | MET-A-FOR | Metabolomic analysis for the forensic detection of drugs of abuse in performance and food producing animals | 2015 |
| 22 | ANTIVIRALS | European Training Network on Antiviral Drug Development | 2015 |
| 23 | MUSICARE | MUltiSectoral Integrative approaches to CArdiac care | 2015 |
| 24 | HyMedPoly | Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications | 2015 |
| 25 | Biorapid | Rapid Bioprocess Development | 2015 |
| 26 | HEARTEN | A co-operative mHEALTH environment targeting adherence and management of patients suffering from Heart Failure | 2015 |
| 27 | REDOXIT | Reactive oxygen species (ROS) as Elixirs against chronic Disease: OXidative regulatory mechanisms In T cells and neutrophils. | 2015 |
| 28 | RAIS | Scalable, point-of-care and label free microarray platform for rapid detection of Sepsis | 2015 |
| 29 | ChemoEnz | Chemo-Enzymatic Manufacturing Routes to High- Value compounds | 2015 |
| 30 | OCN4OS | Organo-Catalytic Nanoparticles for Organic Synthesis | 2015 |
| 31 | MULTISURF | MULTI-functional metallic SURFaces via active Layered Double Hydroxide treatments | 2015 |
| 32 | NANOREACTOR | Multiscale modelling of stimuli-responsive nanoreactors | 2015 |
| 33 | 3MC | 3D Model Catalysts to explore new routes to sustainable fuels | 2015 |
| 34 | ANAPRINT | Additive Printing for Cell-based Analysis | 2014 |
| 35 | ACfoil | Anti-counterfeit foil for security packaging | 2014 |
| 36 | BioGuidePCa | Biomarker Guided Prostate Cancer Management | 2014 |
| 37 | C-BORD | effective Container inspection at BORDer control points | 2015 |
| 38 | microMole | SEWAGE MONITORING SYSTEM FOR TRACKING SYNTHETIC DRUG LABORATORIES | 2015 |
| 39 | iNEXT | Infrastructure for NMR, EM and X-rays for translational research | 2015 |
| 40 | SoNDe | Solid-State Neutron Detector - A new Neutron Detector for High-Flux Applications | 2015 |
| 41 | FLUNOVELTY | Development of novel fluorinated reagents for preparation of drugs. | 2015 |
| 42 | MOSUDO | Water and Drug Mobility at Silica Surfaces probed with DOSY NMR | 2015 |
| 43 | WITHDRAWAL AFTERMATH | The Aftermath of a Drug Withdrawal: Modeling Spillover Effects Across Countries and Across Categories | 2015 |
| 44 | Brain Metastases | The Role of Circulating Monocytes in the Development of Brain Metastases | 2015 |
| 45 | CircaDopamine | The Role of Dopamine in the Regulation of Sleep and Circadian Rhythms | 2015 |
| 46 | Leucophyl | Total Synthesis of Leucophyllidine | 2015 |
| 47 | miROMeS | miRNA biomarkers of Osseous Metastases in Serum from breast cancer patients | 2015 |
| 48 | Cdc42Adhere | Role of Cdc42 in cancer cell adhesion to endothelial cells and platelets | 2015 |
| 49 | PoreSelect | Macroporous Polymer Monoliths as a Low-Cost Bioanalytical Platform for Biopharmaceutical Glycoprotein | 2016 |
| 50 | INSCAPE | Imaging Voltage Gated Sodium Channels Using Positron Emission Tomography | 2015 |
| 51 | NPL | Synthesis of Natural Product Like Compounds for Drug Discovery | 2016 |
| 52 | CHELALZ | Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies | 2016 |
| 53 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
| 54 | ICSIS | The interaction and clearance of senescent vascular cells by the innate immune system | 2015 |
| 55 | AuNP-PhotoBioDrug | Functionalized AuNPs and their use for biological applications | 2015 |
| 56 | LiVirIn | 3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction | 2015 |
| 57 | MSMART | Margination of Microcapsules in Small Arteries | 2015 |
| 58 | REZONABLE | Regeneration and zonation by ZEB2 of Liver Endothelium | 2016 |
| 59 | MediVAC | Bio-sustainable production of natural medicines from Vitex | 2015 |
| 60 | ChemoBOOM | Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy | 2016 |
| 61 | Als-on-a-chip | A tissue-on-a-chip platform for systems-level studies of ALS pathology and drug screening | 2015 |
| 62 | ACPNMR | Structural dynamics of acyl carrier protein complexes through combined solution and solid-state NMR | 2015 |
| 63 | FUNFIT | Fungal resistance to antifungals is promoted by cell heterogeneity | 2015 |
| 64 | BAP | A dynamical view of binding affinity | 2015 |
| 65 | VesSenDrugDeliv | A versatile platform for the design of targeting drug delivery vesicles | 2015 |
| 66 | MetalCell | Transition-Metal Mediated Chemistry in Cells | 2015 |
| 67 | IPEIBD | Identification of promoters and enhancers specific for inflammatory bowel disease and its subtypes | 2015 |
| 68 | MCMQCT | Multi-functional Computational Microscopy for Quantitative Cell Tracking | 2015 |
| 69 | EDD Project | A new EDD detector will give a knowledge for crystallography with the objective to understand nanostructures and for the development of new materials | 2015 |
| 70 | FLUOROKEF | Incorporation of unnatural fluorinated amino acids to probe the function of the bacterial efflux system Kef in a cellular setting. | 2015 |
| 71 | EpiLIVER | Characterization and implications of DNA damage response in liver cancer | 2016 |
| 72 | OPTOFRAX | Optopharmacological brain mapping of autism mouse models | 2015 |
| 73 | SynBiol-DynHet | Diversity in Synthetic Biological Systems | 2015 |
| 74 | Lx Micelles | Coordination chemistry in doubly stabilized micelles for the tageted delivery of cytostatic drugs in cancer therapy | 2015 |
| 75 | MetAccembly | Accelerating metal-directed assembly, recognition and catalysis with computational methods | 2015 |
| 76 | PFSEXOME | Identification of protein kinases and signalling pathways important for Plasmodium falciparum malaria transmission | 2015 |
| 77 | STTDAA | Synthesis of Truncated Tirandamycin A-D Derivatives as new Antihelminthic Agents | 2015 |
| 78 | DrugsUP | Solute carrier proteins and the uptake of cytotoxic approved drugs | 2015 |
| 79 | CARDIOTOX | Predicting Cardiotoxicity Induced by Kinase Inhibitors: From Systems Biology to Systems Pharmacology | 2015 |
| 80 | SENSITIVITYMARKERS | Clinical validation of prognostic biomarkers of chemotherapy response in liquid biopsies | 2015 |
| 81 | Cardiacom IMPLANT | Intelligent human diagnostic and therapy platform | 2014 |
| 82 | Diricore | Exploiting vulnerabilities in protein synthesis for cancer diagnosis and therapy | 2015 |
| 83 | SUMOblock | Blocking SUMO conjugation as drug discovery strategy. | 2015 |
| 84 | USODA | Upscaling Synthesis of Ordered mesoporous silica material for Drug delivery Applications | 2015 |
| 85 | INPACT | Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication. | 2015 |
| 86 | NANOTAM | Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages | 2015 |
| 87 | MgSpa | A highly efficient and eco-friendly electric shower offering health benefits through magnesium sulphate | 2015 |
| 88 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
| 89 | HTMD | Feasibility assessment of a cloud application platform for rational drug design using high throughput molecular dynamics | 2015 |
| 90 | DERMADROP | DERMADROP - A COMPREHENSIVE TRANSDERMAL THERAPY CONCEPT FOR NON- HEALING WOUNDS AND OTHER SKIN DISORDERS | 2015 |
| 91 | RIPEB | Rapid heat inactivation of pathogens to enable biomarker research | 2015 |
| 92 | NanoPaths | Identifying pathways of cellular nanoparticle uptake and early processing for novel nanomedicine applications | 2015 |
| 93 | CONCERT | Description of information transfer across macromolecules by concerted conformational changes | 2015 |
| 94 | ZF-MEL-CHEMBIO | Chemical Biology in Zebrafish: Drug-Leads and New Targets in the Melanocyte Lineage and Melanoma | 2015 |
| 95 | ExtruLub | Commercialisation of Advanced Extrusion Technologies Delivering Disruptive Innovation for the Next Generation of Catheter Based Medical Devices. | 2015 |
| 96 | SilkByPass | Develop simple tissue regeneration technologies for the benefits of humanity by leveraging the biomimetic properties and the mechanical advantages of a new silk manufacturing nanotechnology. | 2015 |
| 97 | AutArt | Clinical validation of the AutArt rheumatoid arthritis diagnostic device | 2015 |
| 98 | BIOINOHYB | Smart Bioinorganic Hybrids for Nanomedicine | 2016 |
| 99 | NeuroNanoChip | A Nano-electrode chip for high-resolution/high-throughput cellular assays in cultured neurons including synaptic tranmission | 2015 |
| 100 | SAMPA | Scale-up of an Advanced Manufacturing process to produce a Pharmaceutical product Application (SAMPA). | 2015 |
| 101 | SPICE | Synthetic Lethal Phenotype Identification through Cancer Evolution Analysis | 2015 |
| 102 | Drug-Seq | Unravelling the Genomic Targets of Drugs Using High-Throughput Sequencing | 2015 |
| 103 | ZAUBERKUGEL | Fulfilling Paul Ehrlich’s Dream: therapeutics with activity on demand | 2015 |
| 104 | BtRAIN | Brain barriers training | 2015 |
| 105 | BioExcel | Centre of Excellence for Biomolecular Research | 2015 |
| 106 | HisMoDetect | An Antibody Microarray for Histone Modifications | 2015 |
| 107 | p38Cure | New breast cancer therapies based on available p38 MAPK inhibitors | 2015 |
| 108 | AIRS | Advanced Intelligent Raman System for detection of explosives and harmful substances at urban soft targets | 2015 |
| 109 | IonoChem | IonoChem: A new and highly efficient cross membrane drug delivery strategy | 2015 |
| 110 | INTESTINANOS | Intestinal Lipoidal Nanostructures - A Lipid Bridge to Increased Drug Delivery | 2015 |
| 111 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 112 | Cancer-Recurrence | Tumor cell death supports recurrence of cancer | 2015 |
| 113 | ISOTOPICS | ISOTOPIC LABELING FOR DRUG INNOVATION | 2016 |
| 114 | AEGIS | Accelerated Early staGe drug diScovery | 2016 |
| 115 | iPROTECTION | Molecular mechanisms of induced protection against sepsis by DNA damage responses | 2015 |
| 116 | resistance evolution | Bacterial evolution of hypersensitivity and resistance against antimicrobial peptides | 2015 |
| 117 | StemNicheOnWaveCrest | New therapies for myeloproliferative diseases based on multi-stage and -system analyses of the haematopoietic stem-cell niche | 2015 |
| 118 | PAINSTRAT | Novel neurophysiological techniques to quantify pain and stratify patients | 2016 |
| 119 | VESCEL | Vascular Engineering on chip using differentiated Stem Cells | 2015 |
| 120 | MASCP | Mechanisms of alternative pre-mRNA splicing regulation in cancer and pluripotent cells | 2015 |
| 121 | SENTINEL | HIV-1 sensing and signaling in dendritic cells | 2015 |
| 122 | 5HTCircuits | Modulation of cortical circuits and predictive neural coding by serotonin | 2016 |
| 123 | COMbAT | Commercialization of a novel tool for designing personalized nOvel MelAnoma Therapies | 2015 |
| 124 | EPOCH28 | Epigenetic Profiling of Chemotherapy Efficacy | 2015 |
| 125 | SUNLIGHTING | Harvesting the Sun | 2015 |
| 126 | CellScreenChip | All-in-One Cell Screening Chip: Device for Affordable High-Throughput Cell Screenings | 2015 |
| 127 | BIOVALID | Clinical validation of the DiviTum assay in two high profile clinical studies in Europe | 2015 |
| 128 | MOZART | MesopOrous matrices for localiZed pH-triggered releAse of theRapeuTic ions and drugs | 2015 |
| 129 | DrugStop | Drug detection for personal protection | 2015 |
| 130 | ALBINO | Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome | 2016 |
| 131 | EndoNaut | EndoNaut Delivery Platform | 2016 |
| 132 | QuatSalts | New Quaternary Ammonium Salts for use in Drug Manufacture | 2016 |
| 133 | BREATHE | EasyFlow: New asthma monitor to enable the effective control of asthma | 2015 |
| 134 | RCC-TEST | A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test | 2016 |
| 135 | TRANSBIO | A BIOmarker-based assay for prognosis and monitoring in renal TRANSplantation | 2015 |
| 136 | LeukoPredict | LeukoPredict: an in vitro system predicting and monitoring the therapeutic response of patients in the cure of Chronic Myeloid Leukemia (CML). | 2016 |
| 137 | DILITEST | Diagnosis and Exclusion of Drug-Induced Liver Injury by using Patient Blood Samples (DILITEST) | 2015 |
| 138 | ImMoRiSt | Immune Monitoring for RIsk STratification in Solid Organ Transplant Recipients | 2016 |
| 139 | OCProDx | Strategic planning for commercialisation of a multiplexed protein diagnostic (Dx) blood test for Organ-Confined Prostate cancer: OCProDx | 2016 |
| 140 | DYNAP | Dynamic Penetrating Peptide Adaptamers | 2016 |
| 141 | microCrysFact | Microfluidic Crystal Factories (μ-CrysFact): a breakthrough approach for crystal engineering | 2016 |
| 142 | DROSADAPTATION | New approaches to long-standing questions: adaptation in Drosophila | 2016 |
| 143 | TAT-CF | Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters | 2016 |
| 144 | UM Cure 2020 | New therapies for uveal melanoma | 2016 |
| 145 | Bcl-Inhib | Discovery of Bcl-3 inhibitors as Potential Chemopreventive Agent for skin cancer | 2015 |
| 146 | COBIOPHAD | COMPACT BIOPHOTONIC PLATFORM FOR DRUG ALLERGY DIAGNOSIS | 2016 |
| 147 | assymcurv | The influence of the cell membrane asymmetry and curvature on the functioning of membrane proteins and the transport of therapeutic compounds | 2016 |
| 148 | PELICO | Peptidomimetics with photocontrolled biological activity | 2016 |
| 149 | nanoBAT | Enhanced brown adipose tissue activity using nanotechnology approaches | 2016 |
| 150 | ePerMed | Rise of scientific excellence and collaboration for implementing personalised medicine in Estonia | 2016 |
| 151 | SAFEIMMUNOSUPPRESS | Development of immunosuppressive treatments with better safety | 2016 |
| 152 | FOLSMART | Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis | 2016 |
| 153 | VIVALDI | Preventing and mitigating farmed bivalve diseases | 2016 |
| 154 | NetMoDEzyme | Network models for the computational design of proficient enzymes | 2016 |
| 155 | PEARRL | Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines | 2016 |
| 156 | TROJANANOHORSE | Hybrid immune-eluding nanocrystals as smart and active theranostic weapons against cancer | 2016 |
| 157 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 158 | channelopathies | Type 1 reyanodine receptor Structure and regulation by post-translational modifications and small molecules. | 2016 |
| 159 | INTEGHER | Integration of herpesvirus into telomeres: From the mechanism of genome integration and mobilization to therapeutic intervention | 2016 |
| 160 | BARCODE DIAGNOSTICS | Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine | 2016 |
| 161 | RNA ORIGAMI | RNA-protein Nanostructures for Synthetic Biology | 2016 |
| 162 | LATE-STAGE | Palladium catalyzed C(sp3)‒H late-stage diversification of biologically active molecules | 2016 |
| 163 | CollBioImag | Development of a cell-based system for high-throughput screening of antifibrotics | 2016 |
| 164 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 165 | MCANALSMSCA2015 | Receptor signalling in space and time - Gaining high-resolution information of the temporal and spatial control of G protein-coupled receptor signalling. | 2018 |
| 166 | INTO | Inorganic therapeutic nanoparticles for osteoporosis | 2016 |
| 167 | CaLiAT | A novel pathway for generation of building blocks for antibiotic biosynthesis | 2016 |
| 168 | MolecularEVOLUTION | Molecular Evolution of the Primary Structure of Single Chain Polymer Nanoparticles via Dynamic Covalent Chemistry | 2016 |
| 169 | NanoCap | Sustainable Polypeptide Nanoparticle Platform for Drug Delivery | 2016 |
| 170 | HeartAtaK | Targeting the Anti-Target: From Structure to Drug in the heart Kv11.1 channel | 2016 |
| 171 | CAMEOS | Cardiac micro-engineered tissue for high-throughput screening | 2016 |
| 172 | OPTBIOMAN | Optimal Decision Making under Uncertainty in Biomanufacturing Operations | 2016 |
| 173 | EHT-CaMKII | CaMKII over stimulation in engineered heart tissues (EHTs) made from human induced pluripotent stem cells (hiPSCs): a parameter involved in the immaturity of hiPSC EHTs cardiomyocytes? | 2016 |
| 174 | PW | Your digital source for medication awareness : “Your health is a choice, choose to know” | 2015 |
| 175 | SynBioGABA | A new biosynthesis procedure for pharmaceutically active gamma-aminobutyric acids | 2016 |
| 176 | SEGU | SEwer inventory system to safeGUard waste water infrastructures | 2016 |
| 177 | FCSSSLP | First Chemoselective Synthesis and Structural Studies of Lasso Peptides | 2016 |
| 178 | MRCKa in cancer | Targeting Cancer Cell Invasion and Metastasis by Inhibition of the Serine Kinase MRCKa | 2016 |
| 179 | ChondUb | Identification and characterisation of novel WWP2 substrates and their role in chondrogenesis and osteoarthritis | 2016 |
| 180 | ChroMe | Chromatin and Metabolism Chromatin-metabolism interactions as targets for healthy living | 2016 |
| 181 | OPTIM | Optimized drug combinations for effective cancer treatment: a personalised approach. | 2016 |
| 182 | SYNVIA | Synthetic viability of homologous recombination-deficient cancers | 2016 |
| 183 | ONCOINTRABODY | Targeting common oncogenes with intracellular monobodies | 2016 |
| 184 | InnateMSDyn | Combining in vivo spectral biphoton imaging and multiparametric cytometry to characterize the dynamics of the innate immune response in a multiple sclerosis mouse model | 2016 |
| 185 | FLUORODRUGS | Smart Theranostic Agents for the Tumour Microenvironment | 2017 |
| 186 | MESO-JBIR-102 | Development of the aza-Prins reaction; synthesis and biological evaluation of JBIR-102 | 2016 |
| 187 | 2MoveMate4Melanoma | A treatment for BRAF inhibitor resistant melanoma | 2016 |
| 188 | IcoCell | Cell line development platform for SMEs to reduce the length and cost of biologic drug development | 2016 |
| 189 | PET3D | PET Imaging in Drug Design and Development | 2016 |
| 190 | SCoTMOF | Combined Chemo- and Radiotherapies by Controlling the Surface Chemistry of Truncated Metal Organic Framework Nanoparticles | 2016 |
| 191 | EpigenomeProgramming | An experimental and bioinformatic toolbox for functional epigenomics and its application to epigenetically making and breaking a cancer cell | 2016 |
| 192 | SafeShore | System for detection of Threat Agents in Maritime Border Environment | 2016 |
| 193 | ENABLE | Elucidating natural bilayer lipid environments | 2016 |
| 194 | MYCLASS | Towards prevention, early diagnosis, and noninvasive treatment of uterine leiomyomas through molecular classification | 2016 |
| 195 | CryoProtect | A new cryoprotectant formulation for the next generation of high throughput screening toxicology tests | 2016 |
| 196 | LSD-CortLVPC | Applying voltage-imaging techniques to visualise the effect of lysergic acid diethylamide (LSD) on cortical layer V pyramidal cells and its adaptation during tolerance development | 2016 |
| 197 | TiDrugArchitectures | Highly Competent and Safe Titanium(IV) Therapeutic Frameworks that are Cancer Targeted based on Complex 1, 2, and 3D Chemical Architectures | 2016 |
| 198 | iCARE | MobIle health-Care system for monitoring toxicity and symptoms in cAncer patients ReceivingdiseasE-oriented therapy | 2016 |
| 199 | iGOLDD | Commercialising MR-HIFU: an Image-Guided Local Drug-Delivery Platform | 2016 |
| 200 | DeCISIoN | Drug CandIdates ScreenINg | 2016 |
| 201 | OZONELASER | Cost and time-effective universal medical device for treatment of onychomycosis by combining several technologies | 2016 |
| 202 | SEIZSAFE | Patient-self-adaptive system for detection, recording and alert to caregivers of night-time seizures, linked to private cloud platform for patient tracking and big data exploitation. | 2016 |
| 203 | USONIPRO | Ultrasonic technology for bioprocess enhancement | 2016 |
| 204 | PCFENCM | Pan-cancer functional evaluation of non-coding DNA mutations | 2017 |
| 205 | IMPAX | Inline/Instant Measurement for PhArma eXtrusion | 2016 |
| 206 | DrugSynergy | DrugSynergy: A data-driven systems biology approach to optimize drug combination strategies | 2016 |
| 207 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
| 208 | BCM-UPS | Dissecting the role of the ubiquitin proteasome system in the pathogenesis and therapy of B-cell malignancies | 2016 |
| 209 | TNT-TUMORS | Therapeutic approaches to enhance innate immunity against Tumors | 2016 |
| 210 | TAROX | Targeting oxidative repair proteins for treatment of cancer and inflammation | 2016 |
| 211 | IMMUNOALZHEIMER | The role of immune cells in Alzheimer's disease | 2016 |
| 212 | AngioResist | Coordinated Development of Inhibitors and Biomarkers for Resistance to Antiangiogenics in Cancer - AngioResist | 2016 |
| 213 | FAST-BM | FAST-BM: FibroSelect: delivering A Step-change in Biotherapeutic Manufacturing | 2016 |
| 214 | SEQUOIA-DD | Boosting productivity and performance in drug discovery with SEQUOIA - Semantic Query of Information Assets | 2016 |
| 215 | NanoSil4Cancer | Smart Multifunctional silica-based Nanoparticles for Targeted Therapy | 2016 |
| 216 | TRIGEM | Unlocking Triterpenoid Structural Diversity and Bioactivity through Genome Mining | 2016 |
| 217 | EYEGET | Gene therapy of inherited retinal diseases | 2017 |
| 218 | SYNOX | Total Synthesis of Biologically Important Pyrrolidinone Natural Products and Analogues Thereof. | 2016 |
| 219 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 220 | LowCostTracking | Low cost tracking and data management solution for biopharma cold chain logistics | 2016 |
| 221 | OcuTher | Educational Network in Ocular Drug Delivery and Therapeutics | 2016 |
| 222 | TREATMENT | Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia | 2017 |
| 223 | Train2Target | An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics: Targeting function and cross-talk of bacterial Envelope proTein machineries | 2017 |
| 224 | CarBon | Controlling Cartilage to Bone Transitions for Improved Treatment of Bone Defects and Osteoarthritis | 2017 |
| 225 | ImageInLife | Training European Experts in Multilevel Bioimaging, Analysis and Modelling of Vertebrate Development and Disease | 2017 |
| 226 | in3 | An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment | 2017 |
| 227 | GameofGates | Solute carrier proteins as the gates managing chemical access to cells | 2016 |
| 228 | OBSTETRICVIOLENCE | Obstetric violence.The new goal for research, policies and human rights on childbirth | 2016 |
| 229 | NOMBIS | Nano-OptoMechanical Systems for Biological Sensors | 2016 |
| 230 | chemos | Chemical Hematology: breaking resistance of hematological malignancies through personalized drug trials | 2016 |
| 231 | isitFlutter | dIagnoSIs app for regular aTrial arrhytmia like Flutter | 2016 |
| 232 | TRANSBIO | Cellular BIOtechnology for prognosis and monitoring in renal TRANSplantation | 2017 |
| 233 | PhotoMedMet | Towards Novel Inert (Photo-)toxic Ru(II) Polypyridyl Complexes | 2016 |
| 234 | NASCENT | Novel Approach to Systematically Characterize Exercise- and Nutrient- responsive genes in Type 2 diabetes and cardiovascular disease | 2017 |
| 235 | STARS | Empowering Patients by Professional Stress Avoidance and Recovery Services | 2017 |
| 236 | EMbRACe | Effective Multidrug Cocktails for Cancer | 2016 |
| 237 | HALODRUGSYN | Innovative Strategies towards Halogenated Organic Molecules: From Reaction Design to Application in Drug Synthesis | 2017 |
| 238 | PLASMECS | NanoPlasmoMechanical Systems | 2016 |
| 239 | BITCAT | Blocking Inhibition of T-cell Co-stimulation for Anti-tumour Therapy | 2017 |
| 240 | CONNEXIO | Physiologically relevant microfluidic neuro-engineering | 2016 |
| 241 | ALZSYN | Imaging synaptic contributors to dementia | 2016 |
| 242 | REUSE4MALARIA | Drug Repurposing for Malaria Chemoprotection | 2016 |
| 243 | TERPENECAT | Bridging the gap between supramolecular chemistry and current synthetic challenges: Developing artificial catalysts for the tail-to-head terpene cyclization | 2016 |
| 244 | SupraCarrier | Supramolecular hydrogels as local controlled drug delivery carriers | 2017 |
| 245 | LysoMod | Genetic and Small Molecule Modifiers of Lysosomal Function | 2017 |
| 246 | MULTIFUNSOME | Anti-EGFR Monoclonal Antibody Conjugated Thermoresponsive Liposome for Triple Negative Breast Cancer Thermo-Chemotherapy | 2017 |
| 247 | IMAGENE | Characterizing Function Genetic Variants Linking Immunity and Psychiatric Disorders | 2017 |
| 248 | PHENOSPACE | Quantifying behavioural phenotype space: chemistry-to-gene screens and combination therapies | 2016 |
| 249 | SWEETBULLETS | Sweet Theranostics in Bitter Infections - Seek and Destroy | 2017 |
| 250 | 3D NEONET | Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics | 2017 |
| 251 | MIMESIS | A novel systems biology approach to develop preclinical assets from innovative drug discovery starting points inspired by viruses | 2016 |
| 252 | N2B-patch | Nose to Brain Delivery of antibodies via the Olfactory Region for the Treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical Device | 2017 |
| 253 | McHAP | Entrapment of Hypoxic Cancer by Macrophages Loaded with HAP | 2017 |
| 254 | NONCODRIVERS | Finding noncoding cancer drivers | 2016 |
| 255 | INHIBITHUMAN | Dis-inhibitory circuits in the human cerebral cortex | 2016 |
| 256 | AlzDiabetes | Insulin resistance and Tauopathy : Insights from Drosophila models and human brain samples | 2016 |
| 257 | NOC | Nerve-on-Chips | 2016 |
| 258 | NOTID | Novel treatment of inflammatory diseases | 2016 |
| 259 | HPE1 | New high-performance excipients in pharmaceutical industry: an innovative solution for a more efficient and sustainable drug manufacturing process. | 2016 |
| 260 | OVOMATIC | IN-OVO AUTOMATION FOR CANCER DRUG DISCOVERY | 2017 |
| 261 | ExtremoChem | Chemically synthesised novel compounds for the stabilisation of biologics | 2016 |
| 262 | 3DCC | Ready-to-use 3D Cell Cultures for early de-risking in drug development | 2016 |
| 263 | Mini Brains | Cerebral organoids: human mini brains in a dish open up new possibilities for drug development in neurodegenerative and developmental diseases | 2017 |
| 264 | miRCaP | Innovative nanoparticle formulation for a miR-133 based treatment of cardiac hypertrophy | 2016 |
| 265 | DAMOC | Diabetes Approach by Multi-Organ-on-a-Chip | 2017 |
| 266 | IllegalPharma | Competitive Dynamics in the Informal Economy: The case of Illegal Pharmaceutical Drugs | 2017 |
| 267 | Halo | Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets | 2017 |
| 268 | MagnaPharm | Magnetic Control of Polymorphism in Pharmaceutical Compounds | 2017 |
| 269 | One-Flow | Catalyst Cascade Reactions in ‘One-Flow’ within a Compartmentalized, Green-Solvent ‘Digital Synthesis Machinery’ – End-to-End Green Process Design for Pharmaceuticals | 2017 |
| 270 | FANCODRUG | Reactivation of the Fanconi anemia-BRCA pathway in cells carrying patient-derived missense mutations: finding a drug to cure Fanconi anemia | 2017 |
| 271 | MONONANOCHEM | In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer | 2017 |
| 272 | NinZA | Theranostic molecular zipper based switchable nanomedicine for overcoming drug resistance | 2017 |
| 273 | BETASCREEN | Validation of an in vivo translational medicine approach for the treatment of diabetes and diabetes complications | 2017 |
| 274 | SpheroPredict | A 3D advanced test for prediction of drug response in secondary liver cancer | 2017 |
| 275 | CryoBiopsy | CryoBiopsy: a bi-modal temperature sample preservation device for standardized breast cancer biopsy | 2017 |
| 276 | Bronchomycn | First in class epithelial Barrier-enhancing medicine for respiratory diseases | 2017 |
| 277 | NAUPLIUS | ELIMINATION OF PARASITIC COPEPOD IN FARMED SALMON | 2017 |
| 278 | RELEASE | Nanofiber based drug delivery for surgical therapy of adult and paediatric solid tumours | 2017 |
| 279 | DePharm | A cost-effective and energy-efficient water treatment technology to remove pharmaceutical pollutants from urban wastewater | 2016 |
| 280 | CancerFluxome | Cancer Cellular Metabolism across Space and Time | 2017 |
| 281 | AMPK-DIAB | A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novelinnovative drug for the treatment of type 2 diabetes | 2016 |
| 282 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 283 | THUNDER | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | 2017 |
| 284 | SULIPRO | A scientifically proven, safe, naturally derived drug for the effective treatment of liver damage - an innovative solution for a significant unmet medical need | 2017 |
| 285 | TEDCIP | Targeting epigenetic demethylases: development of covalent inhibitors and PROTACs (Proteolysis Targeting Chimeras). | 2017 |
| 286 | LIGER | Identification of novel substrates for ubiquitin ligases involved in cell cycle and cell migration | 2017 |
| 287 | Targeting TopoII | Mechanistic studies of metal-dependent DNA cleavage in Type II topoisomerase toward therational design of novel anticancer drugs | 2017 |
| 288 | Stress Imaging | Nanoscale Stress Imaging with Imperfect Diamonds | 2017 |
| 289 | GlycoModels | 3D glyco-engineered models to address the role of glycosylation in gastric cancer clinical management | 2017 |
| 290 | metabolicomp | Computational dynamics studies of drug metabolism by P450 enzymes | 2017 |
| 291 | EPI-Centrd | Epilepsy Controlled with Electronic Neurotransmitter Delivery | 2017 |
| 292 | FLUDD | Late Stage Fluorination and its Applications to Drug Discovery | 2017 |
| 293 | 3DPD | PhD position in commercial environment: cancer immunotherapy drug screening in 3D | 2017 |
| 294 | TheranOMICS | Integration of high resolution -OMICS datasets towards personalized therapy in bladder cancer | 2017 |
| 295 | CMI2T IA | Harmless Clostridium bacteria as a highly targeted, continuous delivery system for immunomodulatory anti-cancer drugs | 2017 |
| 296 | MAREXT | Macrocyclic receptors for selective anion extraction | 2018 |
| 297 | BRAINHIB | Integrated drug discovery approach to generate brain-penetrant inhibitors of glioblastoma cell proliferation | 2018 |
| 298 | DOC | Dark Ocean Cosmeceuticals -DOC-: The Cosmetical and Pharmaceutical Potential of Marine Dissolved Organic Matter | 2017 |
| 299 | TSPO METALLODRUGS | Novel, highly effective and selective anticancer metallodrugs | 2018 |
| 300 | CRISTONE | Targeting CRISPR-based HDAC inhibitors to histones: a new tool for assessing mechanisms of class I HDAC inhibitors and developing chemical probes. | 2017 |
| 301 | PGXOME | A pharmacogenomic exploration of adverse drug reactions in epilepsy | 2017 |
| 302 | DrugSearchTool | Innovative FRET-based toolkit for screening of drugs to fight miRNA-related diseases and its use in the development of cancer treatment with miRNA-96 as a therapeutic target | 2018 |
| 303 | PhoRAu | Photochemistry and radiolabelling of gold(III) anticancer prodrugs | 2018 |
| 304 | TRIBBLES | Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma | 2018 |
| 305 | PHOTORNA | Development of photoswitchable ligands for the reversible and selective assembly with RNA | 2017 |
| 306 | RECREPEMLE | Recombination-derived replication in the eukaryotic microbe Leishmania: a genome-wide process? | 2017 |
| 307 | BioMedBC | Molecular profiling of Bladder Cancer to support personalized medicine | 2017 |
| 308 | APACHE | Atmospheric Pressure plAsma meets biomaterials for bone Cancer HEaling | 2017 |
| 309 | TOXANOID | Pharmacological safety testing in human adult stem cell-derived organoids | 2017 |
| 310 | HUNTINFISH | Generation of new zebrafish models for the study of the pathogenesis of Huntington´s disease and for the identification of new therapeutic targets. | 2018 |
| 311 | RNAatHD | Development of a high-resolution method to monitor structural changes of regulatory RNAs and therapeutic oligo-nucleotides directly in-cell. | 2017 |
| 312 | DesProtDNA | Computational design of proteins binding nucleosomal DNA with specificity for therapeutic applications | 2017 |
| 313 | ESSEVOL | Adapting to Change: Experimental Evolution of Environmental Sensing Systems in Bacteria | 2017 |
| 314 | FimH-Mech | The molecular mechanism of E. coli FimH pathogenicity | 2017 |
| 315 | StressEBOV | Ebola virus manipulation of the cellular stress responses | 2017 |
| 316 | BICEPSvsHIV | Novel strategies for anti-HIV-1 therapy: Small molecules targeting RNA partners of the nucleocapsid protein | 2017 |
| 317 | TNFaLysMyr | Unique TNFα lysine myristoylation; elucidating its function, regulation and integration into inflammation | 2018 |
| 318 | AcTaferon | Revitalizing the clinical potential of type I IFNs in fighting influenza A virus infections with AcTaferon. | 2017 |
| 319 | MOOAC | Multi-compartmental Organ-on-a-Chip | 2018 |
| 320 | PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 | 2016 |
| 321 | IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | 2017 |
| 322 | PlasmoCycle | DNA dynamics in the unusual cell cycle of the malaria parasite Plasmodium falciparum | 2017 |
| 323 | IDRAM | The role of amphidial drug uptake in the mode of action and resistance to ivermectin in nematodes of livestock | 2017 |
| 324 | MIDAS | Predictive modelling of GPCR druggable allosteric sites | 2017 |
| 325 | CAR ART | Chimeric Antigen Receptor to generate Alloantigen-specific Regulatory T cells and promote allograft tolerance | 2017 |
| 326 | NARCOREADER | Novel electrochemical strategies for rapid, on-site multiscreening of illicit drugs | 2017 |
| 327 | INTER | Innovative Neutron source for non destructive TEsting and tReatments | 2017 |
| 328 | LABEL-DIOX | Late-stage catalytic carboxylation techniques with labelled carbon dioxide: new opportunities for radiolabelling | 2017 |
| 329 | IndiviStat | Individualizing statin therapy by using a systems pharmacology decision support algorithm | 2017 |
| 330 | ContraNPM1AML | Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia | 2017 |
| 331 | PHRD | The development of Personalised Host Response Diagnostic kit | 2017 |
| 332 | STARFISH DNA | Stalling the Replication Fork via the Impedimental Stabilization of Higher-order DNAs | 2017 |
| 333 | ZECARDIO | Cardiotoxicity High-throughput screening (HTS) with zebrafish embryo | 2017 |
| 334 | INFISS | Targeting infertility associated to defective Insulin/IGF-1 signalling | 2017 |
| 335 | LUMABS | Therapeutic antibody drug monitoring using bioluminescent sensors proteins and a smartphone | 2017 |
| 336 | NanoMOFdeli | Design of NanoMOFs Capsules for Drug Delivery and Bioimaging. | 2017 |
| 337 | VIPS | Venomics In Predator-prey Systems | 2017 |
| 338 | CHIMERA | A novel instrument to identify chiral molecules for pharmaceutics and bio-chemistry. | 2017 |
| 339 | CoaguPOC | SMART POINT-OF-CARE DEVICE FOR SELF-PATIENT MANAGEMENT OF THE ORAL ANTICOAGULANT THERAPY | 2017 |
| 340 | DrugComb | Informatics approaches for the rational selection of personalized cancer drug combinations | 2017 |
| 341 | TryptoBoost | Boosting tryptophan fluorescence with optical nanoantennas to watch label-free protein dynamics with single molecule resolution at high concentration | 2017 |
| 342 | FORENSICS | Illicit Markets, Unobserved Competitors, and Illegal Behavior | 2017 |
| 343 | SMALLOSTERY | Single-molecule spectroscopy of coordinated motions in allosteric proteins | 2017 |
| 344 | GENDOSIS | GENOTYPE - ENDOPHENOTYPE ASSOCIATIONS IN PSYCHOSIS | 2017 |
| 345 | DeShield | Hide and Seek with Cancer Drugs | 2017 |
| 346 | TIGITtherapy | TIGIT therapy for cancer treatment | 2017 |
| 347 | BUNGEE | Directed crop breeding using jumping genes | 2017 |
| 348 | BreathSpec | A rapid, non-invasive, cost-effective, analytical device for bacterial or viral infection diagnosis through ultra-high sensitivity breath analysis. | 2017 |
| 349 | ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | 2017 |
| 350 | PEVIA | PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088 | 2017 |
| 351 | ChAMPioN | Game-changing Precision Medicine for Curing All Myeloproliferative Neoplasms | 2018 |
| 352 | AIDViC | Antibiotic intracellular delivery via virus-like carriers | 2017 |
| 353 | ANDRUPOS | Automatic non-destructive recognition of used printing techniques on substrates | 2017 |
| 354 | ACUSLABS | A new tool in drug development: mapping of compound-protein interaction using forward genetics | 2017 |
| 355 | ANALYTICS | All-electrical analytic platform for digital fluidics | 2017 |
| 356 | PainCells | Decomposition of pain into celltypes | 2017 |
| 357 | PROBIOTEARS | Probiotic-based Ophtalmologic treatment for Bacterial and Allergic Conjunctivitis | 2017 |
| 358 | SocialDiabetes | Hack your Diabetes Experience | 2017 |
| 359 | VOLSIGNAL | Volume regulation and extracellular signalling by anion channels | 2017 |
| 360 | CodeSphere | CodeSphere - Discovering Therapeutic Nanoparticles by Molecular Encoding | 2017 |
| 361 | ZEBRAONCOFISH | Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics | 2017 |
| 362 | EuroNeurotrophin | A European training network for the discovery of neurotrophins small molecule mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation | 2018 |
| 363 | iDESIGN | Delivering Better Starting Points for Drug Discovery: New Compound Libraries Driven By Intelligent Design | 2018 |
| 364 | IGNITE | Comparative genomics of non-model invertebrates | 2018 |
| 365 | META-CAN | Targeting the metabolism-immune system connections in Cancer | 2017 |
| 366 | PhD4GlycoDrug | Multidisciplinary European Joint Doctorate in the Design and Development of Glyco Drugs | 2017 |
| 367 | SAFER | Selective Agonists For Serotonin Receptors | 2017 |
| 368 | SAGAPROPLUS | A Unique Herbal Product for the Symptomatic Treatment of Over Active Bladder | 2017 |
| 369 | PIC | Personalised In-Silico Cardiology | 2017 |
| 370 | LightDyNAmics | DNA as a training platform for photodynamic processes in soft materials | 2018 |
| 371 | CellPrintArray | CellPrintArray – on-demand nano-scale printing of live cells and compounds for miniaturized cell screening applications | 2017 |
| 372 | RTCure | Rheuma Tolerance for Cure | 2017 |
| 373 | Imaging-XChem | Imaging-XChem: A computational package for ultrafast electronic control in chemistry | 2017 |
| 374 | CRIMTANG | Criminal Entanglements.A new ethnographic approach to transnational organised crime. | 2018 |
| 375 | onCOMBINE | Towards evidence-based combinations of approved and novel cancer drugs | 2017 |
| 376 | ImPRESS | Imaging Perfusion Restrictions from Extracellular Solid Stress | 2018 |
| 377 | FarCatCH | Innovative Strategies for Unprecedented Remote C-H bond Functionalization by Catalysis | 2018 |
| 378 | TarMyc | Targeting the Oncogenic Function of Myc in vivo | 2018 |
| 379 | BugTheDrug | Predicting the effects of gut microbiota and diet on an individual’s drug response and safety | 2018 |
| 380 | FattyCyanos | Fatty acid incorporation and modification in cyanobacterial natural products | 2018 |
| 381 | FAITh | Fighting Anxiety with Importin-based Therapeutics | 2017 |
| 382 | ORBIS | Open Research Biopharmaceutical Internships Support | 2018 |
| 383 | AstroNeuroCrosstalk | Astrocyte-Neuronal Crosstalk in Obesity and Diabetes | 2018 |
| 384 | SONGBIRD | SOphisticated 3D cell culture scaffolds for Next Generation Barrier-on-chip In vitro moDels | 2018 |
| 385 | STRONG | Strong Coupling Between Molecules and Vacuum Fields: New Molecular Properties | 2018 |
| 386 | ERACHRON | Eradicating Chronic Infections | 2018 |
| 387 | SilkFUSION | Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research | 2017 |
| 388 | CfC | Carrier for Cure: tailored combination drug delivery solutions for oncology | 2017 |
| 389 | SWINOSTICS | Swine diseases field diagnostics toolbox | 2017 |
| 390 | RECOPHARMA | Removal and Recovery of Pharmaceutical Persistent Pollutants from Wastewater by Selective Reagentless Process | 2018 |
| 391 | CISTEM | Heart On chip based on induced pluripotent Stem cell Technology for personalized Medicine | 2018 |
| 392 | safenolaTiCancerDrug | Highly and Widely Effective, Water Stable, and Non Toxic Titanium-Phenolato-based Anticancer Chemotherapy | 2017 |
| 393 | DIDO-MS | Commercialization of a first in class multiple sclerosis drug | 2018 |
| 394 | BIOSIM | Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence | 2017 |
| 395 | GeroProtect | Developing Geroprotectors to Prevent Polymorbidity | 2017 |
| 396 | ORI NUMBER | Unravelling the effect of origin number on the success of genome replication | 2017 |
| 397 | GOTBONE | Novel mechanisms of site-specific regulation of bone strength for the prevention of osteoporotic fractures: a translational project | 2017 |
| 398 | NANOCARGO | Photo/magnetic stimulated nanocargos for superior cancer treatments | 2018 |
| 399 | EURO SHOCK | Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock | 2018 |
| 400 | MTrix | Mechanical Targeting as an Integrative Approach for Personalized Nanomedicine | 2017 |
| 401 | bloodANDbone | Blood and bone – conjoined twins in health and disease: bone marrow analogs for hematological and musculoskeletal diseases | 2018 |
| 402 | TRIBAL | A TRranslational approach to Identify Biomarkers for Asthma and Lung function impairment | 2017 |
| 403 | transtryp | Structural differences in mRNA translation machineries between eukaryotic pathogens and their mammalian hosts | 2018 |
| 404 | ToMeTuM | Towards the Understanding a Metal-Tumour-Metabolism | 2018 |
| 405 | REPO-TRIAL | An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes | 2018 |
| 406 | REMIX | Regenerative Medicine Innovation Crossing - Research and Innovation Staff Exchange inRegenerative Medicine | 2017 |
| 407 | Nano-OligoMed | Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications | 2017 |
| 408 | COLOSTEO | Nutraceutical supplementation based on colostrum for prevention of osteoporosis | 2018 |
| 409 | MATADOR | MAmmary chemoresistant Tumor deAth by Directed cell ORientation | 2018 |
| 410 | OneRNA4Bladder | Non invasive Cell Based Liquid Biopsy Platform for Bladder Cancer | 2017 |
| 411 | SDS-OmiProbe | Revolutionary opto-biological methodology for aggressive HER2 cancer | 2017 |
| 412 | INTACT | Imaging NM: A Nanoparticulate Precision Medicine Approach to Target Cancer | 2017 |
| 413 | N-IF | The N-IF mouse – a new and unique fibrosis model for preclinical efficacy studies | 2017 |
| 414 | BioAhead | BioAhead – an innovative optimization algorithm for amino acid chain analytics | 2017 |
| 415 | Brain2Bee | How dopamine affects social and motor ability - from the human brain to the honey bee | 2018 |
| 416 | NovAnI | Indentification and optimisation of novel anti-infective agents using multiple hit-identification strategies | 2018 |
| 417 | CLLCLONE | Harnessing clonal evolution in chronic lymphocytic leukemia | 2018 |
| 418 | MicroCaT | Micro-tumor Guided Cancer Therapy Selection MicroCaT | 2018 |
| 419 | ClearRing | An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms. | 2018 |
| 420 | AuriMod | From pills to bio-electronics: a wearable anti-inflammatory treatment for prevention of Peripheral Arterial Disease. | 2018 |
| 421 | oWBI | Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery | 2018 |
| 422 | PulseHaler | PulseHaler: Improving the Lives of COPD Patients | 2017 |
| 423 | BTech | Novel human neurodegenerative disease specific 3D cell-models with applications in drug development and toxicity testing | 2018 |
| 424 | GREENSENSE | Sustainable, Wireless, Autonomous Nanocellulose-based Quantitative DoA Biosensing Platform | 2018 |
| 425 | REMATCH | Image-based analysis for drug discovery and repurposing | 2018 |
| 426 | ProTeAN | Production and Testing of humAn-derived Neurons and brain organoids: advanced model probing in neurodevelopmental disorders | 2018 |
| 427 | 3DProSeed | 3DProSeed: the first ready-to-use, pre-assembled, hydrogel microtiter plate for 3D cell culturess | 2018 |
| 428 | ChronosAntibiotics | Exploring the bacterial cell cycle to re-sensitize antibiotic-resistant bacteria | 2018 |
| 429 | BCPPlus | New directions in bicyclopentane research | 2018 |
| 430 | CF3-DIAZOMETHYLATOR | Photocatalytic C–H Bond CF3-diazomethylation | 2018 |
| 431 | SYNFOS | Synthetic toolkit for fragment oriented synthesis | 2018 |
| 432 | SmallDrugRheuma | Discovery of Immune Therapeutic Targets and Immunomodulators for the Development of Novel Therapies in Rheumatoid Arthritis. | 2018 |
| 433 | MISFIRES | Misfires and Market Innovation: Toward a Collaborative Turn in Organising Markets | 2018 |
| 434 | CaLecLig | Calcium-dependent Lectins in Human Pathogenic Infections: From Atomistic Understanding to Ligand Design | 2018 |
| 435 | IPACBIS | Identifying preclinical Alzheimer´s disease in the community using a panel of biomarkers among individuals with Subjective Memory Complaints | 2018 |
| 436 | SoftNanoHybrid | Polymer-Nanoparticle co-assembly for drug targeting and release kinetics: Investigation on Structure, Morphology, Responsiveness, and Nanoparticle distribution | 2018 |
| 437 | INTERGLU | Dissecting mGlu5 receptor internalization pathways using genetic and pharmacological tools | 2018 |
| 438 | FINDER | FINDER: FIghtiNg DEngue viRus, a novel strategy for the development of fully protective antiviralsthat act by disrupting the DENV NS3/NS5 interaction | 2018 |
| 439 | XQCR | Electronic structure and energy descriptors for molecular crystals from quantum crystallography and X-ray charge density analysis | 2018 |
| 440 | MaGMa | Applying Metabolomics to Unveil follow-up treatment biomarkers and Identify Novel TherapeuticTargets in Glioblastoma | 2018 |
| 441 | ChromaFish | Chromatographic micro-column development for pharmaceutical applications in zebraFish | 2018 |
| 442 | DNAProteinCrossRep | Identification of DNA-Protein-Crosslink Repair Factors | 2018 |
| 443 | DYNAFLUORS | Dynamic Activatable Fluorophores | 2018 |
| 444 | EnCAge | Progeria models to study endothelial cell ageing: implications for organ regeneration and fibrosis | 2020 |
| 445 | ICON-BIO | Integrated Connectedness for a New Representation of Biology | 2018 |
| 446 | PREVENT RA | Towards prevention of autoimmune diseases: the case of rheumatoid arthritis | 2018 |
| 447 | ANITA | Advanced tools for fighting oNline Illegal TrAfficking | 2018 |
| 448 | RECGLYCANMR | Breaking the limits in glycan recognition by NMR | 2018 |
| 449 | SEXinMALARIA | Sex in malaria parasites – from basic biology to targets for transmission blocking interventions. | 2018 |
| 450 | SCCMMI | Single cell correlates of memory, motivation and individuality | 2018 |
| 451 | TCELLTIGIT | Structural characterization of immune signaling protein TIGIT using x-ray crystallography and cryo-electron microscopy | 2019 |
| 452 | EXCITATOR | Active probing of brain excitability by electrical micro-stimulations for drug discovery | 2018 |
| 453 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 454 | TheraSonix | Ultrasonic Imaging and Drug Propulsion Into Tumors Using Genetically Encoded Gas Nanostructures | 2018 |
| 455 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 456 | NaKStruc | Structural studies of Na,K-ATPase isoforms and mutants | 2018 |
| 457 | ASTRO_ECM | Deciphering the role of astrocytes in chronic depression. | 2018 |
| 458 | ORTHOCAT | Bioorthogonal Photocatalytic Activation of Metal-Based Prodrugs | 2018 |
| 459 | MECH-LoC | Mechanically tuned Lung-on-a-Chip device to model pathology and drug screening for lung disease | 2018 |
| 460 | HIV VCC Interference | Characterisation of single molecule dynamics within HIV-1 reservoirs as a target for interference with virus persistence and immune evasion | 2019 |
| 461 | NEUROTARGET | Treatment of traumatic brain injury using dye-loaded polymeric nanoparticles | 2018 |
| 462 | VIAR | Virus-induced autophagy restriction | 2018 |
| 463 | rSAMs-NANO | Nanoparticles with switchable shells for virus sensing and inhibition | 2018 |
| 464 | PhotoCuRiOT | Visible Light-Mediated Copper Photoredox-Catalyzed Ring-Opening Transformations of Activated Small Ring Aza-Heterocycles and Carbacycles | 2018 |
| 465 | PREMEDiCARE | PREcision MEDicine with induced pluripotent stem cells for Cardiac Arrhythmias Risk Evaluation | 2018 |
| 466 | SCOUT | Supporting Causal Conclusions from Observational Survival Studies | 2018 |
| 467 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
| 468 | iCHEMGENODRUGS_TB | Chemogenomics and in silico repurposing as an innovative approach for rapid drug discovery in tuberculosis | 2018 |
| 469 | rDNAstress | Novel insights into DNA damage and stress responses in the nucleolus: Mechanisms and relevance for genomic (in)stability and cancer | 2019 |
| 470 | SquaMem | Interaction of squalene-based anti-cancer and neuroprotective drugs with cell membranes: in silico study | 2018 |
| 471 | Spectro-Metrics | Advanced Data Mining Procedures Applied to Raman Spectroscopy Investigations of Interactions between Drugs and Cells. | 2018 |
| 472 | AvINFLUENZA | Molecular basis of avian influenza polymerase adaptation to human hosts | 2019 |
| 473 | SPArKLE | New players in immunometabolism: investigating the role of succinate and pyruvate kinase in T cell immunity | 2018 |
| 474 | EpiBarrier | Control of the blood-brain barrier integrity during seizures via the ATP-gated P2X7 receptor | 2018 |
| 475 | GlycoPCs | How do Pharmacological Chaperones work? Molecular basis of the actions of glycomimetics on keyglycosidases involved in lysosomal storage disorders | 2018 |
| 476 | DETRIMODE | DEgradation TRIggered by MOdular DEsign | 2018 |
| 477 | NeuroVU | NeuroVU: Real-time Sensing in Microfluidic Models of the Neurovascular Unit | 2018 |
| 478 | ProCenDecl | Synthesis and validation of chemical Probes for Centrosome Declustering: development of potent and selective anti-cancer agents. | 2019 |
| 479 | DIRECT Therapies | Diabetes Immunoengineering: Redesigning Encapsulated Cell Transplant Therapies | 2018 |
| 480 | GEMZ | Genetic Epilepsy Models in Zebrafish | 2019 |
| 481 | UNNAMEd-2 | Unraveling the conceptional novel ADAM17 regulation by PP2A in metastasis formation. | 2019 |
| 482 | transLEISHion | A targeted knockout screen for identification of Leishmania membrane transporters required for infection of macrophages | 2018 |
| 483 | IN-3D-CAN | Instrumented 3D-Printed Miniature Muscles for Cardiotoxicity Screens of Cancer Therapies | 2018 |
| 484 | GLYMPHARMA | Modulation of the glymphatic system: a novel tool for drug delivery to the central nervous system | 2018 |
| 485 | TANWORM | How do tannins kill parasitic worms? | 2019 |
| 486 | TAMYOCAL | Tamoxifen mediated protection on X-linked centronuclear myopathy: a mechanistic and pre-clinical study | 2018 |
| 487 | TakeupSLaCk | Role and regulation of dendritic cell functions by Solute Carrier Transporters | 2019 |
| 488 | kANNa | Knowledge graph completion using Artificial Neural Networks for Herb-Drug Interaction discovery | 2019 |
| 489 | PFS | A cost- energy-efficient treatment technology to remove pharmaceutical pollutants from water | 2018 |
| 490 | IMI-PainCare | Improving the care of patients suffering from acute or chronic pain | 2018 |
| 491 | 4DBIOSERS | Four-Dimensional Monitoring of Tumour Growth by Surface Enhanced Raman Scattering | 2018 |
| 492 | NanoBioNext | Nanoscale Biomeasurements of Nerve Cells and Vesicles: Molecular Substructure and the Nature of Exocytosis | 2018 |
| 493 | MAPSYNE | Miniaturized automated patch-clamp system combined with high-density microelectrode arrays for multi-scale functional mapping of neuronal networks | 2018 |
| 494 | AlloGPCR | Allosteric modulation of G-protein Coupled Receptors conformational landscape | 2018 |
| 495 | Pan3DP | 3D bioprinting of pancreatic tissue for biomedical research | 2018 |
| 496 | TALVIN | Inhibiting mechanotransduction for the treatment of pancreatic cancer | 2018 |
| 497 | B2B | Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity. | 2018 |
| 498 | MiCaBra | Mitochondrial Cannabinoid Receptors in the Brain | 2018 |
| 499 | SENCAN | Senescence therapy for cancer | 2018 |
| 500 | REPLICHROMA | Eukaryotic DNA replication: a single-molecule approach to the study of yeast replication on chromatin | 2018 |
| 501 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 502 | UCRxF | A novel ulcerative colitis treatment - A phase III ready feasibility study | 2018 |
| 503 | Lab-on-Skin | Lab-on-Skin: A wearable medical device for improved clinical trial monitoring | 2018 |
| 504 | RheumArth | New drug for the treatment of rheumatoid arthritis | 2018 |
| 505 | TherGelFas | Novel nanometrically structured therapeutic hydrogel as injectable for fascial tissues surrounding the nerves intended for preventive treatment of chronic pain | 2018 |
| 506 | PAH-HOPE | New hope for the PAH patient: A Novel Therapeutic for Pulmonary Arterial Hypertension (PAH) | 2018 |
| 507 | GENBIO | Reducing the cost, time, and ethical burden of preclinical research in the pharmaceutical industry | 2018 |
| 508 | iMOTED | iMOTED Platform Built to improve Clinical Trial outcomes | 2018 |
| 509 | PICARD | Disruptive GPCR Lead Discovery Platform Delivering New and Safer Therapeutics | 2018 |
| 510 | prudenta | Prudenta: Electronic Solution for Safer Drugs | 2018 |
| 511 | EREDETIO | Wearable Device for Erectile Dysfunction Diagnostics and Treatment Monitoring | 2018 |
| 512 | KHON2bTREAT | Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market | 2018 |
| 513 | BrainBase | Knowledge management platform for clinical use of brain data | 2018 |
| 514 | SkinKer | Absorbable and wearable keratin-based nanofibers for wound healing and skin reconstruction | 2018 |
| 515 | Sea4Pain | Development of a novel analgesic for chronic pain from marine-derived compounds | 2018 |
| 516 | Stellar i-ris | First non-invasive, reliable and quickest biometric system detecting users’ fatigue and narcotics consumption for road safety and the prevention of accidents at safety-critical workplaces in Europe | 2018 |
| 517 | THERMONANO | Nanoassemblies for the subcutaneous self-administration of anticancer drugs | 2018 |
| 518 | MolPredict | Neural-based solution to boost drug preclinical research success | 2018 |
| 519 | MOBIUS | MØBIUS: Transforming medication management for improved patient safety | 2018 |
| 520 | LYSADERM | Platelet LYSAte based DERMal formulation for the treatment of skin ulcers | 2018 |
| 521 | Separative | Disruptive purification consumables for the pharmaceutical industry | 2018 |
| 522 | CircaCHIP | Development of Circadian Rhythms on Chip | 2018 |
| 523 | DelNAM | Strengthening the Research Area of Delivery of Nucleic acid mimics (NAMS) into bacteria to fight the antibiotic crisis | 2018 |
| 524 | ONCOSMART | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2018 |
| 525 | WOUNDCOM | Interactive biomembranes for wound management – exploiting the unique wound healing and antimicrobial properties of human collagen VI | 2018 |
| 526 | SIGNIA | SIGNIA: An innovative drug discovery platform for rapid identification and validation of antimicrobial applications in available pharmaceutical resources and drugs open for repurposing. | 2018 |
| 527 | NeuroProtect | Novel Drug Therapy with Potential to Cure Neuro-Degenerative Diseases | 2018 |
| 528 | SERKET | Artificial Intelligence for Livestock Health Management. | 2018 |
| 529 | FORMBECC | LaminarPace System: a breakthrough technology for dry-formulation of sensitive pharmaceuticals at room temperature enhancing their stability beyond the cold chain | 2018 |
| 530 | SECReTE | Enhancing biological drug production through protein secretion | 2018 |
| 531 | 2shRNA | 2shRNA branched nanobinders as promising therapeutic tools for combined cancer therapy | 2019 |
| 532 | mP-CSE | Micro-physiological circadian platform for safety and efficacy assessment of drugs and cosmetics | 2018 |
| 533 | HISTOID | A Human iPS Cell-Derived Artificial Skeletal Muscle for Regenerative Medicine, Disease Modelling and Drug Screening | 2018 |
| 534 | PML-THERAPY | HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY | 2019 |
| 535 | PATH-TOX | Artificial Intelligence to transform Drug and Chemical safety testing | 2018 |
| 536 | Treat-HSP | Development of new therapy for rare motor neuron diseases | 2018 |
| 537 | REACT | REsponsive theranostic nanosystems for Advanced Cancer Treatment | 2019 |
| 538 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
| 539 | MOAB | Miniaturised optically accessible bioreactor for drug discovery and biological research | 2018 |
| 540 | FitteR-CATABOLIC | Survival of the Fittest: On how to enhance recovery from critical illness through learning from evolutionary conserved catabolic pathways | 2018 |
| 541 | BERMES | A Novel BERberine derivative for Malignant MESothelioma | 2018 |
| 542 | Secreters | A new generation of microbial expression hosts and tools for the production of biotherapeutics and high-value enzymes | 2019 |
| 543 | WHILYAS | Wound healing ILYA-style | 2018 |
| 544 | MechanoIMM | Mechanical Immunoengineering for Enhanced T-cell Immunotherapy | 2018 |
| 545 | PoLiMeR | Polymers in the Liver: Metabolism and Regulation | 2018 |
| 546 | AIMS-2-TRIALS | Autism Innovative Medicine Studies – 2 – Trials | 2018 |
| 547 | RiboInflam | Assessing the role of ribosomes and mRNA translation in shaping the inflammatory response | 2019 |
| 548 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
| 549 | NanoMed-CKD | Feasibility of mCura1: A kidney-targeted nanomedicine that promotes self-healing of Chronic Kidney Disease with messenger RNA. | 2018 |
| 550 | CORolla | "CORolla® - a disruptive ""spring like"" metallic device for permanent treatment of diastolic heart failure." | 2018 |
| 551 | CARE | COMMON ACTION AGAINST HIV/TB/HCV ACROSS THE REGIONS OF EUROPE | 2019 |
| 552 | ENDOSCAPE | ENDOSCAPE, a clinically applicable non-viral gene delivery technology | 2019 |
| 553 | BioExcel-2 | BioExcel-2 Centre of Excellence for Computational Biomolecular Research | 2019 |
| 554 | HOPE | automatic detection and localization of High frequency Oscillation in Paediatric Epilepsy | 2019 |
| 555 | VeCare | Selective retention of VEGF for cancer and retinopathies therapeutics | 2019 |
| 556 | REMIND | Targeting pathological synaptic pruning by microglia in neurodegeneration | 2019 |
| 557 | LUMAX | Innovative Laser and Fiber System for Non-Toxic, Efficient and Cost-Effective Treatment of Cancer | 2018 |
| 558 | ABRSEIST | Antibiotic Resistance: Socio-Economic Determinants and the Role of Information and Salience in Treatment Choice | 2019 |
| 559 | NUMA-SCALE | Enabling Large-Scale GMP-ready Peptide Production with a new, reliable and cost-efficient Bioprocess | 2018 |
| 560 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
| 561 | HiMISER | High resolution Miniature Implantable nerve Stimulator for Electroceutical Research (HiMISER) | 2019 |
| 562 | LINCE | Light INduced Cell control by Exogenous organic semiconductors | 2019 |
| 563 | IntegraBrain | Integrated Implant Technology for Multi-modal Brain Interfaces | 2019 |
| 564 | GIOTTO | Active aGeIng and Osteoporosis: The next challenge for smarT nanobiOmaterials and 3D technologies | 2019 |
| 565 | EVPRO | EVPRO - Development of Extracellular Vesicles loaded hydrogel coatings with immunomodulatory activity for Promoted Regenerative Osseointegration of revision endoprosthesis | 2019 |
| 566 | SELNET | Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network | 2019 |
| 567 | NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | 2019 |
| 568 | PHIVIDIAS | Preclinical Human In Vitro Drug Immune Response Analysis Platform | 2019 |
| 569 | WhisperSense | Whispering Gallery Modes (WGM) for label free bioanalytics | 2019 |
| 570 | ZebraZoom | ZebraZoom: Kinematic analysis for drug and genetic screening in zebrafish | 2018 |
| 571 | The MATRIX | Inflammatory resolution and remodelling of the adipose extracellular matrix: key determinants of a metabolically healthy phenotype? | 2019 |
| 572 | SUPRANET | Supramolecular Recognition in Dynamic Covalent Networks at Equilibrium and Beyond | 2019 |
| 573 | SYSTEM | SYnergy of integrated Sensors and Technologies for urban sEcured environMent | 2018 |
| 574 | EPIORGABOLISM | Diabetic nephropathy modelling in hESC-derived 3D kidney organoids | 2019 |
| 575 | BARINAFLD | Using Bariatric Surgery to Discover Weight-Loss Independent Mechanisms Leading to the Reversal of Fatty Liver Disease | 2018 |
| 576 | HYPROTIN | Hyperpolarized Nuclear Magnetic Resonance Spectroscopy for Time-Resolved Monitoring of Interactions of Intrinsically Disordered Breast-Cancer Proteins | 2019 |
| 577 | FutureTrophicFactors | Elucidating therapeutic effects and mode of action of future trophic factorsin ALS and Parkinson’s disease | 2019 |
| 578 | 3DLT | 3D Living Tissues | 2019 |
| 579 | BBBhybrid | Advanced in vitro physiological models: Towards real-scale, biomimetic and biohybrid barriers-on-a-chip | 2019 |
| 580 | StopAutoimmunity | Recurrent disease in the liver transplant: window to identify and stop gut signals driving autoimmunity | 2019 |
| 581 | NEOCANTAL | New Oleocanthal-based functional ingredients with anti-inflamatory properties obtained from olive pomace valorisation | 2019 |
| 582 | Capsulight | The first ingestible capsule for eradicating Helicobacter pylori infection through photodynamic therapy | 2019 |
| 583 | EMC2 | Extreme-scale Mathematically-based Computational Chemistry | 2019 |
| 584 | TALE | Therapeutic Allele Engineering: A novel technology for cell therapy | 2019 |
| 585 | Agglomerates | Infinite Protein Self-Assembly in Health and Disease | 2019 |
| 586 | uCARE | Understanding Circumventing Antibiotic REsistance | 2019 |
| 587 | MICROB-PREDICT | MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response | 2019 |
| 588 | BioMensio | BioMensio mobile biosensing platform: the first truly palm-sized and accurate digital multi-drug test | 2019 |
| 589 | SpartWISE | Reinventing fine chemicals synthesis: large-scale production of sparteine from lupin beans | 2019 |
| 590 | MP-101 | a novel drug for prevention and treatment peripheral neuropathy symptoms | 2019 |
| 591 | ThermoEye | ThermoEye an innovative system for pigs' fever early detection | 2019 |
| 592 | NANOFLOWSIZER | Developing a disruptive and revolutionary tool for real time inline nanoparticle size measurement, for superior quality control and process efficiency. | 2019 |
| 593 | AllergyVAX | Next generation allergen immunotherapy based on specifically modified recombinant hypoallergens | 2018 |
| 594 | DNACom | Compartmentalized DNA Computers for In-Vitro Diagnostic Applications | 2019 |
| 595 | CancerFingerPrints | Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis | 2019 |
| 596 | NeuroDeRisk | Neurotoxicity De-Risking in Preclinical Drug Discovery | 2019 |
| 597 | Cluster-Buster | Development of small molecule inhibitors of circulating tumor cell clusters | 2019 |
| 598 | CRC-MTOs | Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing | 2018 |
| 599 | AIRWAVES | Automated high resolution water sampler for environmental monitoring | 2019 |
| 600 | SAVANA | Massive reutilization of Electronic Health Records (EHRs) through AI to enhance clinical research and precision medicine | 2018 |
| 601 | ProtMind | Protecting Minds: The Right to Mental Integrity and The Ethics of Arational Influence | 2020 |
| 602 | 20SInhibitor | Selective 20S proteasome inhibition for multiple myeloma therapy | 2019 |
| 603 | AgePhagy | An integrated high-throughput human cell and Drosophila screening platform for the expedited discovery of anti-ageing compounds | 2019 |
| 604 | EV-2C | Structural and functional studies of enterovirus 2C proteins: promising targets for antiviral therapy. | 2019 |
| 605 | DiPipe | Direct remote C-H functionalization in piperidine derivatives | 2019 |
| 606 | REAP | Repair of DNA lesions induced by platinum drugs | 2019 |
| 607 | hsPCF-FRET | Real-time characterisation of neuropeptide binding to a membrane receptor involved in pain and ischemic stroke | 2019 |
| 608 | GPCR-MS | Molecular Details of Membrane Protein Receptor Dynamics | 2019 |
| 609 | THERMOGUIDE | Optimizing delivery and effectiveness of chemotherapy in breast cancer patients using thermotherapy under image-guidance | 2019 |
| 610 | deCrYPtion | Decrypting Mycobacterium cytochrome P450 (CYP) physiological functions by testing hypotheses emitted form large-scale comparative genomics analysis | 2019 |
| 611 | ChOLLATERAL | Generation of an adverse outcome pathway network on cholestatic liver injury for mechanism-based in vitro testing of chemicals. | 2019 |
| 612 | N-STRAINED | Nitrogen-Radical-Based Radical Strain-Release Strategies for the Divergent Assembly of Polyfunctionalized 3D-Building Blocks | 2019 |
| 613 | ImmunoMECH | High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment | 2019 |
| 614 | Need2immune | Personalized liposomal cancer vaccines within days by rapid formulation screening | 2019 |
| 615 | NPsVLCD | Natural Product-Inspired Therapies for Leishmaniasis and Chagas Disease | 2019 |
| 616 | RuCat | New Horizons in C–H Activation: the ‘Real-World Molecules’ Challenge | 2019 |
| 617 | pyrroQuin | Synthesis and Biological Evaluation of Pyrroquinoline Pseudo-Natural Products | 2020 |
| 618 | ACTAN | Automatic Control of Anaesthesia | 2019 |
| 619 | BacDrug | Bacterial membrane vesicles a novel delivery system for the treatment of multi-drug resistant Gram-negative bacterial infections. | 2020 |
| 620 | F4TGLUT | Food for thought: monitoring the effects of drugs and diet on neuronal glutamate release using nanoelectrodes | 2019 |
| 621 | ProDelivery | High Throughput Synthesis of Polymeric Vesicles for Protein Delivery | 2019 |
| 622 | SNFWD | A pH-Responsive Bionanohybrid Nanofibrous Wound Dressing | 2019 |
| 623 | DADA2GT | Development of gene therapy and genome editing strategies to treat adenosine deaminase 2 deficiency | 2019 |
| 624 | MODSIM | Modelling of Twin Screw Granulation on Micro-Macro Scales | 2019 |
| 625 | AstroCOMET | Astrocyte-neuron COmmunication in METabolism and obesity. | 2020 |
| 626 | ICE-METs | Interstitium-on-a-chip to explore its role in cancer metastasis | 2019 |
| 627 | TBNANO | Targeted intracellular delivery of antitubercular agents by functionalized nanocapsules | 2019 |
| 628 | POLAR STAR | Polymeric cyclodextrin-based nanoparticles for combination therapy of castrate-resistant prostate cancer | 2019 |
| 629 | ElectroCatFlow | Fluorination of Aryl Halide Compounds under Electrochemical-Flow Conditions | 2019 |
| 630 | 3D NKCC1 | Interdisciplinary approach to characterize the structure and the ion transport mechanism of NKCC1, a key target for brain disorders. | 2019 |
| 631 | DynaPIC | Dynamic bonds and polyion complex (PIC) nanoparticles for targeted intracellular peptide delivery | 2020 |
| 632 | BioNanoProbes | Bio-Inspired Glycan-NanoProbes as Antimicrobial Pro-Drugs | 2019 |
| 633 | PHOTOCYLINDER | Photodynamic therapy enabled DNA-fork-binding metallo-cylinders: drugs and release triggers | 2019 |
| 634 | PMSMatTrain | Novel Biomaterial-based Device for the Treatment of Progressive MS- - An Integrated Pan- European Approach | 2019 |
| 635 | SLIPPED | Maintenance and relapse in long-term desistance from crime and recovery from addiction | 2019 |
| 636 | BorderSens | Border detection of illicit drugs and precursors by highly accurate electrosensors | 2019 |
| 637 | SiGNATURE | Selection of human iPSC-derived cardiomyocytes by sinGle cell geNe expression and pAtch clamp for a maTUre caRdiac modEl | 2020 |
| 638 | NEUROSKIN | Modulating skin innervation to treat cutaneous inflammation | 2019 |
| 639 | MICROX | Microscopy of living cancer cells at physiological oxygen levels: the MICROX platform | 2019 |
| 640 | ELECTROSULF | Electrochemical Sulfonylation of Lysine Residues in Continuous Flow Microreactors. | 2019 |
| 641 | SUPERBRAIN | Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy | 2020 |
| 642 | MIMIC | Mapping and modulating integrin mediated interactions | 2020 |
| 643 | LCxLCProt | Comprehensive two-dimensional liquid chromatography for the characterization of protein biopharmaceuticals at the protein level | 2020 |
| 644 | MS4Drug | An Innovative Mass Spectrometry-Based Workflow for Drug Discovery | 2019 |
| 645 | TargetGBM | Generating a targeted, brain-permeable and stable polymeric nanoparticle for systemic gene delivery to glioblastoma | 2019 |
| 646 | signalling dynamics | Bridging biophysics and cell biology: The role of G protein-coupled receptor conformations in signalling | 2020 |
| 647 | BITFORM | Multiplexed biosensing and tissue-on-a-chip integrated platform for breast cancer biomarkers monitoring | 2019 |
| 648 | Vetherapy | Regenerative medicine for cost- and time-efficient pet treatment | 2019 |
| 649 | NO-GO | NO-GO: UNVEILING THE POWER OF C-08 FOR THE TREATMENT OF OVER ACTIVE BLADDER | 2019 |
| 650 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
| 651 | INFarm | A unique, interferon-based veterinary therapy to minimize antimicrobial overuse in cattle and tackle the societal global problem of antimicrobial resistance | 2019 |
| 652 | BRIGHT | 40 Hz Masked Light: A new venture to slow the progression of Alzheimer’s Disease | 2019 |
| 653 | MS-INFINITE | MASS SPECTROMETRY WITHOUT LIMITS: Pioneer MS equipment and Automated Sample Preparation unit to boost New Therapies Development | 2019 |
| 654 | ISACS | Improving Safety and comfort for kidney transplanted patients by enabling Accurate therapeutic drug monitoring through quantitative Capillary home Sampling | 2019 |
| 655 | HELP | Collaboration for innovation: Establishment of a pan-nematode drug development platform | 2019 |
| 656 | QuiescStemGBM | Studying the role of Quiescent Cancer Stem Cells in GBM development using a novel in vivo cell cycle-based approach | 2020 |
| 657 | ConcePTION | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation | 2019 |
| 658 | GlycoMabs | Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies | 2019 |
| 659 | EuReCa | Institut Curie EuReCa PhD Programme | 2020 |
| 660 | Aseptic Smart | World’s first unmanned, fully aseptic multi-functional commercial filling line for the bio-/pharmaceutical industry | 2019 |
| 661 | iLCA | Intelligent Live Cell Analysis [iLCA] to transform disease management through faster, and more regulatory robust, discovery, manufacture and monitoring of biologic drugs & cell therapies | 2019 |
| 662 | RespiriTB | Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors | 2019 |
| 663 | RespiriNTM | Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs | 2019 |
| 664 | PWD | Novel technology for industrial Pressing, Washing and Drying in manufacturing of specialty compounds | 2019 |
| 665 | SCANRESIST | Reversal of anti-cancer drug resistance | 2019 |
| 666 | His-Li mouse | His-Li mouse, the unique humanized mouse model resembling human liver and immune systems | 2019 |
| 667 | SUPAIR Spectroscopy | SUPAIR Spectroscopy: Single-Use Process Analytical Infrared Spectroscopy | 2019 |
| 668 | O-POINTED | Osteoarthritis patient cohorts in the dish - personalised cellular drug development tools for osteoarthritis precision medicine | 2019 |
| 669 | SaPhaDe | Know your enemy: systematic discovery of Salmonella anti-Phage Defences for the improved design of phage therapeutics | 2019 |
| 670 | SPLITVAC | Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines | 2019 |
| 671 | KINETICfinder | KINETICfinder: A disruptive method to determine kinetic profiles in drug discoveries | 2019 |
| 672 | RESTORE | RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients | 2019 |
| 673 | ALCO-ADO | Unveiling the alcohol-dependent alterations in local dendritic translation of mRNAs in the prefrontal cortex during adolescence | 2019 |
| 674 | PTOoC | Plug-n-Play Tool-kit of Organ-on-Chips | 2019 |
| 675 | AL4BIOCH | Assembly Lines for Biocombinatorial Chemistry | 2019 |
| 676 | ProTeCT | Proteasome as a target to combat trichomoniasis | 2019 |
| 677 | MetEpiC | P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis | 2020 |
| 678 | KOALA FOCUS | KOALA FOCUS: A disruptive e-health approach to treat at home, attention deficits without drugs | 2019 |
| 679 | STREPUNLOCKED | Unlocking the antibiotic production potential in soil bacteria Streptomyces coelicolor | 2019 |
| 680 | NEXIM | A Next-generation targeted immuno-oncology therapy | 2019 |
| 681 | Nano_Brain | Improving drug delivery to the brain and glioblastoma treatment using temperature. | 2019 |
| 682 | TOPAS | Exploiting the Tumor Proteome Activity Status for Future Cancer Therapies | 2019 |
| 683 | ARCH | AGE-RELATED CHANGES IN HEMATOPOIESIS | 2019 |
| 684 | ActiTOX | Active organotypic models for nanoparticle toxicological screening | 2019 |
| 685 | GNA NOW | NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW | 2019 |
| 686 | NEXTER | Next generation eco-friendly, microbiome preserving and reduced resistance therapeutics | 2019 |
| 687 | OPIOIDREWARD | How distress alters opioid drug effects and abuse liability | 2019 |
| 688 | MAREP | MAssive intracellular REcording for Pharmacology | 2019 |
| 689 | MABIOS | The first microalgae platform for the production of anticancer biopharmaceuticals | 2019 |
| 690 | Promitil | Promitil® - a new ‘smart’ nanomedicine for cancer chemo-radiotherapy. | 2019 |
| 691 | 24G | 24G: Accurate and Reliable Health Genetic Tests | 2019 |
| 692 | DrugPhosphoProfiler | Accelerating drug and biomarker discovery through a new proteomic service: DrugPhosphoProfiler | 2019 |
| 693 | Light4Sight | Light-activated carriers for the controlled delivery of therapeutic peptides in posterior segment eye diseases | 2019 |
| 694 | MYODM-FSMP | New food for special medical purposes to nutritionally manage Myotonic Dystrophy type 1 | 2019 |
| 695 | AGRICAM | AGRICAM – reducing the usage of antibiotics and increasing animal welfare through advanced thermal imaging system for detecting early cases of mastitis in dairy cows | 2019 |
| 696 | ESPS | Epileptic Seizure Prediction System (ESPS) - Predicting and preventing epileptic seizures based on respiratory biofeedback & machine learning. | 2019 |
| 697 | TWO-BIRDS | A feasibility study for SYT-510, a first-in-class drug to treat neuropsychiatric disorders through restoring overall balance in brain chemistry | 2019 |
| 698 | SYNPEP | Synthetic biology of non-ribosomal peptide synthetases to generate new peptides | 2019 |
| 699 | miPLUNGER | Novel premium pre-filled syringe plunger made by micro- /injection moulding for innovative drug delivery systems and auto injectors | 2019 |
| 700 | PrevictDrugs | Smartphone Measured Eye-Based Digital Biomarkers for Drug Use Detection | 2019 |
| 701 | RASMAC | Regulatory Approved Software for Mutation Analysis in Cancer | 2019 |
| 702 | IMMUNOTRAP | Diagnosis test for immuno-oncology therapies. | 2019 |
| 703 | AntiHelix | DNA helicases in genome maintenance: from molecular and cellular mechanisms to specific inhibitors as potential drugs | 2019 |
| 704 | MIRIADE | Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis | 2019 |
| 705 | SINERGIA | advanced technologieS for drug dIscovery and precisioN mEdicine: in vitRo modellinG human physiology and diseAse | 2019 |
| 706 | II-LCA | Integrated Imaging in live Cell Analysis (II-LCA), for enhanced development and manufacturing of biologic and cell therapies. | 2019 |
| 707 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
| 708 | In-Cytes | IN-CYTES A HIGH-DENSITY MICROELECTRODE ARRAY PLATFORM FOR LARGE-SCALE INTRACELLULAR FUNCTIONAL ASSAYS | 2019 |
| 709 | HeatNMof | Heating triggered drug release from nanometric inorganic-metal organic framework composites | 2020 |
| 710 | PRECODE | PancREatic Cancer OrganoiDs rEsearch Network | 2019 |
| 711 | 3DCanPredict | Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy | 2019 |
| 712 | VETEX | Deep Vein Thrombosis; A Paradigm Change in Treatment through Drug-Free Clot Removal | 2019 |
| 713 | Mirnagreen | First scalable food-grade technology for the direct extraction and purification of miRNAs-rich extracts from plants | 2019 |
| 714 | PreMeDosE | Precision Medicine via Diagnostic Enzyme Activity Testing | 2020 |
| 715 | NeutroCure | Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. | 2020 |
| 716 | mRNA NanoDeli | Application of RNA nanotechnology for delivery of mRNA therapeutics | 2019 |
| 717 | CLASSY | Cell-Like ‘Molecular Assembly Lines’ of Programmable Reaction Sequences as Game-Changers in Chemical Synthesis | 2019 |
| 718 | FLIX | FLow chemistry for Isotopic eXchange | 2020 |
| 719 | SUBFISH | The high-tech offshore and seabed fish farming system the next marine aquaculture generation | 2019 |
| 720 | SELMA | Trial Ready Small Vessel MRI Markers: Proof of Concept | 2019 |
| 721 | METACELL | Artificial metabolic cells for biomanufacturing of bio-based chiral fine chemicals | 2020 |
| 722 | Magicbullet Reloaded | Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy | 2019 |
| 723 | ClearRing | An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms | 2019 |
| 724 | SAND | Secretion, Autophagy and their role in Neurodegeneration | 2019 |
| 725 | SALSETH | Innovative bio-inspired sensors and microfluidic devices for saliva-based theranostics of oral and systemic diseases | 2019 |
| 726 | PICARD | DISRUPTIVE GPCR LEAD DISCOVERY PLATFORM DELIVERING NEW AND SAFER THERAPEUTICS | 2019 |
| 727 | MCBD | MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE | 2019 |
| 728 | NEUROPA | Non-invasive dynamic neural control by laser-based technology | 2020 |
| 729 | NEUREKA | A smart, hybrid neural-computo device for drug discovery | 2019 |
| 730 | Immune-Image | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies | 2019 |
| 731 | Aware | Aiding Antibiotic Development with Deep Analysis of Resistance Evolution | 2019 |
| 732 | NOVACHIP | Novel vascular-like BBB-on-a-chip | 2020 |
| 733 | HemaXis DX | A patient-friendly blood collection device that produces pure plasma samples for simple laboratory analysis | 2019 |
| 734 | SONOBOTS | Acousto-Magnetic Micro/Nanorobots for Biomedical Applications | 2019 |
| 735 | InPreSS | International Pregnancy Safety Study | 2020 |
| 736 | NoBiasFluors | Non-biased fluorescent dyes as markers of drugs for optical in cellulo and in vivo imaging | 2020 |
| 737 | ChronicPain | New Target and Drug Candidates for Alleviating Chronic Pain | 2019 |
| 738 | MaxONCO | A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer | 2020 |
| 739 | BacterOMIC | Intelligence for precision therapies against antimicrobial resistance: The first diagnostic panel that probes all the clinically relevant antibiotics at once | 2019 |
| 740 | SA-VOIR | Assessing the feasibility of MT-011, a first-in-class drug to treat glaucoma and other neurodegenerative diseases via a breakthrough mechanism-of-action | 2019 |
| 741 | BREAK | Blue light remote analgesia with K+ channels | 2019 |
| 742 | HyperBiota | Exploring the diet-microbiota axis for immunomodulation and organ protection in hypertension | 2020 |
| 743 | uHeart | A beating Heart-on-Chip for pre-clinical early detection of drugs cardiac safety | 2019 |
| 744 | ONco-Energetics_OFF | Dissection of Bioenergetic Plasticity of Tumors | 2020 |
| 745 | ELDICO ED | ELDICO ED, Shaping the Future of Crystallography - The First Pure Electron Diffraction Equipment for Nano-Crystallography | 2019 |
| 746 | NeuroPa | Targeting the brain sigma-1 receptor: A paradigm shift for the treatment of neuro-degenerative disorders | 2019 |
| 747 | REVERT | taRgeted thErapy for adVanced colorEctal canceR paTients | 2020 |
| 748 | RESCUER | RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER. | 2020 |
| 749 | MOFCTP | Micro-scale optofludics control based on thermoplasmonic effect of nanoparticle arrays | 2020 |
| 750 | InflaPML | Promyelocytic leukemia protein (PML) outside the tumor: a new player in the control of inflammation | 2020 |
| 751 | CardioProtectMI | A New Drug Therapy for the treatment of ST Elevated Myocardial Infarction | 2019 |
| 752 | RD-MRI NETWORK | BRIDGING THE GAP BETWEEN ACADEMIA & CLINICAL TRIALS FOR THE DEVELOPMENT OF RARE DISEASE TREATMENTS VIA NUCLEAR MAGNETIC RESONANCE IMAGING (MRI) | 2020 |
| 753 | STI-001 | Turn Cancer Immunotherapy Effective in Most Patients | 2019 |
| 754 | HAP2 | Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia | 2020 |
| 755 | ARON | Assay-Ready Organ Network | 2020 |
| 756 | DC-ren | Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren) | 2020 |
| 757 | ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | 2020 |
| 758 | 3D-PIV | Valorization trajectory of a 3D particle image velocimetry instrument | 2020 |
| 759 | PANACHE | Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases. | 2020 |
| 760 | Meta-Targeting | Macro-Nanomedicine to Treat Metastatic Cancer | 2020 |
| 761 | PDPcardio | Protein phosphatase 1-disrupting peptides: Scope and mechanism of action in the treatment of heart insufficiency | 2020 |
| 762 | nanoDNArepair | Next Generation Nanofluidic Devices for Single Molecule Analysis of DNA Repair Dynamics | 2020 |
| 763 | iNEXT-Discovery | Infrastructure for transnational access and discovery in structural biology | 2020 |
| 764 | DAN | High-performance, kiosk-solution for forensic darknet analysis to gain cyber threat intelligence for companies and greatly enhance efficiency and capabilities of European investigation authorities | 2019 |
| 765 | HyperCube | HyperCube: Gram scale production of ferrite nanocubes and thermo-responsive polymer coated nanocubes for medical applications and further exploitation in other hyperthermia fields | 2020 |
| 766 | Glue2Degrade | Therapeutic hijacking of E3 Ligases | 2020 |
| 767 | DYNOME | Barcoding gene expression dynamics at single-molecule resolution | 2020 |
| 768 | Trep-AB | Repurposing clinically approved antibacterial drugs for treponematoses therapy | 2020 |
| 769 | mARs | mARs: Mobile DNA driven antibiotic resistance spreading: molecular strategies, control and evolution for broad distribution | 2021 |
| 770 | THERA | Therapeutic Drug Monitoring with Smartphone-integrated Surface Enhanced Raman Spectroscopy | 2020 |
| 771 | DIANA | Organ-on-a-chip Drug screenIng device to tArget braiN diseAse | 2020 |
| 772 | PArtCell | Physiologically Crowded Artificial Cells for Relevant Drug Screens | 2020 |
| 773 | ICE_PACK | Polymer Materials for Cryogenic Storage and Distribution of Biologics | 2020 |
| 774 | TRANSLATIONAL | A new translational strategy for tailored treatment of type 2 diabetes | 2020 |
| 775 | ClickandTreatCancer | Ligand Directed NIR-based Theranostic Prodrugs for Prostate Cancer | 2020 |
| 776 | HESSP | Hippocampus Extracellular Space Simulator Project (HESSP) | 2020 |
| 777 | Cells in Matrix | Cells in Matrix – an innovative 3D model for R&D of Diabetes | 2020 |
| 778 | SynWaiXen | Total Synthesis of Waixenicin A and Xenibellol A | 2020 |
| 779 | MicroMISTRANS | Error-prone protein synthesis in fungal pathogens Microsporidia: its scope and potential therapeutic targeting | 2020 |
| 780 | ChiCC | Chirality via Cross-Coupling: New Asymmetric C-C Bond Formations Driven by Atom and Step Economy | 2020 |
| 781 | DiStRes | Disentangling the stringent response to engineer novel anti-persister drugs | 2020 |
| 782 | BESG | Bioengineered exosomes based approaches for the effective treatment of non-small cell lung cancer | 2020 |
| 783 | TARNEPC | Targeting treatment-induced neuroendocrine prostate cancer | 2021 |
| 784 | SmartHeart | SmartHeart, a 3D in vitro assay for improved assessment of cardiac drug efficacy and toxicity | 2020 |
| 785 | DINAMIC | A digestion and absorption mimicking bench-top intestinal model | 2020 |
| 786 | FUSION | Single Molecule Imaging-based design of HIV-1 vaccines | 2020 |
| 787 | Immuno-Predictor | Mechanical Biomarkers for Prediction of Cancer Immunotherapy | 2020 |
| 788 | ACQUIRE | Assessing cardiac Contractility and Quantification of Underlying mechanisms In vitro via Response in Excitation-contraction coupling | 2020 |
| 789 | MAP-AD | A multimodal approach to accelerate drug discovery and development in Alzheimer’s disease | 2021 |
| 790 | ICG68-PROG | Imaging of c-Met aberrant cancers with Gallium-68 chelators for positron emission tomography | 2020 |
| 791 | NOSCAR | decipheriNg Oncogenic SIgnalling patterns to break CAncer drug Resistance | 2020 |
| 792 | CLEAR | ComputationaL dEsign optimization for unpolluted wAteR | 2020 |
| 793 | COMMiT | Cancer Organoids Multiplexed Screening in Microfluidic Textile chips | 2020 |
| 794 | HTS MALDI-TOF MDD | MALDI-TOF mass spectrometry metabolite screening assays for drug discovery in human disease | 2020 |
| 795 | COSMos | Chemistry of Sponge Microbiomes | 2020 |
| 796 | EscaPI | Exploring the non-genetic (i.e. ePIgenetic) mechanisms that contribute to therapy Escape in melanoma | 2020 |